Sar­to­rius en­ters into part­ner­ship with Nova Bio­med­i­cal

BioSpectrum (India) - - SUPPLIER NEWS -

Sar­to­rius Ste­dim Biotech (SSB) an­nounced an agree­ment with Nova Bio­med­i­cal to in­te­grate their BioPro­file FLEX2 into the ambr multi-par­al­lel biore­ac­tor sys­tems for au­to­mated, at­line cell cul­ture an­a­lyt­ics. Both the BioPro­file FLEX2 an­a­lyzer and the par­al­lel bio­pro­cess­ing func­tion­al­ity of the ambr cre­ate a unique tool able to si­mul­ta­ne­ously run, sam­ple and an­a­lyze a mas­sive num­ber of cell cul­ture con­di­tions dur­ing high-through­put cell line, me­dia and process de­vel­op­ment by De­sign of Ex­per­i­ments (DoE). This will al­low bio­phar­ma­ceu­ti­cal com­pa­nies to de­velop well-char­ac­ter­ized cell cul­ture pro­cesses in less time while pre­vent­ing the process de­vel­op­ment bot­tle­neck be­ing shifted to the an­a­lyt­i­cal lab­o­ra­tory. The part­ner­ship will de­liver full in­te­grated an­a­lyt­ics for the ambr 15 cell cul­ture sys­tem in Q3 2017 and later in 2017 for the ambr 250 high through­put. The ambr plat­form mim­ics the char­ac­ter­is­tics of clas­si­cal biore­ac­tors at the mi­croscale by al­low­ing au­to­mated par­al­lel pro­cess­ing of sin­gle-use biore­ac­tors.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.